Neuigkeiten

Neuigkeiten aus dem GMP-Umfeld und von der Valicare GmbH

Nachrichten aus aller Welt

Unser internationaler Pressespiegel zeigt eine Auswahl an Nachrichten und neusten Artikel zu den Themen Arzneimittel neuartiger Therapien (ATMP), Chimäre Antigenrezeptor(CAR)-T-Zell-Therapie, Tumor infiltrierende Lymphozyten (TIL) und biotechnologisch bearbeitete Gewebeprodukte (TEP).

Tumor-on-chip modeling of organ-specific cancer and metastasis

24.07.2021 | Science Direct

Abstract Every year, cancer claims millions of lives around the globe. Unfortunately, model systems that accurately mimic human oncology – ...

Chemotherapy can induce mutations that lead to pediatric leukemia relapse

23.07.2021 | Medical Xpress

Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in ...

Erste ambulante CAR-T-Zell-Therapie

22.07.2021 | Management & Krankenhaus

European Commission Approves Bluebird Bio’s Gene Therapy for CALD - Global Genes

21.07.2021 | Global Genes

Rare Daily Staff The European Commission has granted marketing authorization to Bluebird Bio’s Skysona, a one-time gene therapy for the ...

Money on the Move: July 14 – 21

21.07.2021 | Bio Space

Published: Jul 21, 2021 By Kate Goodwin More money means more progress for potentially life-saving therapies. Here's a peek at some ...

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters

21.07.2021 | Frontiers

The immunotherapeutic treatment of various cancers with an increasing number of immune checkpoint inhibitors (ICIs) has profoundly improved ...

FDA Approves StrataGraft for Treating Thermal Burns in Adults

21.07.2021 | U.S. Pharmacist

In a press release on June 15, 2021, the FDA announced the approval of StrataGraft (allogeneic cultured keratinocytes and dermal ...

Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome

21.07.2021 | The Canadian Business Journal

Pipeline Update: Status of Clinical Development for Multiple Sclerosis

20.07.2021 | neurologylive

The state of care for multiple sclerosis (MS) has evolved drastically in the last decade, with much of the development of disease-modifying ...

Clinical Catch-Up: July 12-16

19.07.2021 | Bio Space

Published: Jul 19, 2021 By Mark Terry It was a moderately busy mid-summer week for clinical trial news. Here’s a look. COVID-19-Related ...

BioNTech übernimmt Kites Neoantigen-TCR-Zelltherapie-Plattform sowie Produktionsstätte im amerikanischen Gaithersburg

19.07.2021 | BAWAG P.S.K. Chartmix

MAINZ, Deutschland & Santa Monica, USA 19. Juni 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) und Kite, ein Unternehmen der Gilead-Gruppe ...

B7-H3/CD276: An Emerging Cancer Immunotherapy

19.07.2021 | Frontiers

Immunotherapy aiming at suppressing tumor development by relying on modifying or strengthening the immune system prevails among cancer ...

Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility

16.07.2021 | BioPharm International

The GMP facility is designed to maximize bioprocessing efficiency of newborn stem cells and manufacturing at scale.

EMA OKs Biomarin’s New Application to Approve Roctavian

16.07.2021 | Hemophilia News Today

The European Medicines Agency (EMA) has validated BioMarin Pharmaceutical’s new application seeking approval of its investigational one- ...

Celltrion's Monoclonal Antibody Treatment for COVID-19, regdanvimab (CT-P59), Demonstrates Strong Neutralising Activity Against Delta Variant

16.07.2021 | The Financial Post

Wir sind für Sie da

Kontaktieren Sie uns, wenn Sie Fragen haben. Wir antworten und beraten Sie gerne. 

Kontakt